Type 2 & other diabetes

Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study

BMJ Open Diabetes Res CarePublished Retrospective cohort study

Authors' conclusion

SARS-CoV-2 infection confers a higher risk for developing persistent diabetes 5 months post-COVID-19 in patients with prediabetes who were hospitalized for COVID-19 compared with COVID-19-negative counterparts with prediabetes. In-hospital diabetes, critical illness, and elevated HbA1c are risk factors for developing persistent diabetes. Patients with prediabetes with severe COVID-19 disease may need more diligent monitoring for developing P-DM postacute SARS-CoV-2 infection.

Study context

Population
Patients with history of prediabetes, Montefiore Health System, Bronx, New York, March 11, 2020 to August 17, 2022propensity matched
Participants
3,102 vs 9,306
Exposure
COVID-19 vs no COVID-19 in patients with prediabetes
  • COVID-19n = 3,102
  • Controlsn = 9,306reference
Outcome
New-onset in-hospital DM (I-DM) and new-onset persistent DM (P-DM)
Follow-up
5 months after SARS-CoV-2 infection
Methodological detailspropensity-matched controls, electronic medical record data
  • Propensity-matched controls
  • Electronic medical record data

Main finding

As reported in the abstract

I-DM and P-DM, hospitalized patients · 5 months postinfection (P-DM)
  • COVID-19 vs Without COVID-19: P < 0.001
  • COVID-19 vs Without COVID-19: P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeP value
P-DM, non-hospitalized · 5 monthsCOVID-19 vs Without COVID-19 · similar incidence: 4.15% and 4.1%P > 0.05

Predictors of I-DM

Critical illness, HR
4.6 (3.5 to 6.1), p<0.005 (95% CI)
In-hospital steroid treatment, HR
2.88 (2.2 to 3.8), p<0.005 (95% CI)
SARS-CoV-2 infection status, HR
1.8 (1.4 to 2.3), p<0.005 (95% CI)
Hemoglobin A1c (HbA1c), HR
1.7 (1.6 to 1.8), p<0.005 (95% CI)

Predictors of persistent diabetes mellitus (P-DM) at follow-up

I-DM, HR
23.2 (16.1 to 33.4), p<0.005 (95% CI)
Critical illness, HR
2.4 (1.6 to 3.8), p<0.005 (95% CI)
HbA1c, HR
1.3 (1.1 to 1.4), p<0.005 (95% CI)

Original publication

Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study. BMJ Open Diabetes Res Care. Published 9 June 2023. doi:10.1136/bmjdrc-2022-003257

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.